3rd Translational Research Conference
Chronic Lymphocytic Leukaemia
Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek

3rd Translational Research Conference
Chronic Lymphocytic Leukaemia
Information
ABOUT THE CONFERENCE:
The ESH 3rd Translational Research Conference: Chronic Lymphocytic Leukaemia proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.
It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in Chronic Lymphocytic Leukaemia (CLL) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behaviour of the disease.
The presentation of new data is encouraged, as well as spirited debates on how to use this knowledge to the future of CLL therapy.
SCIENTIFIC TOPICS:
• CLL disease progression
• Richters syndrome
• Biomarkers: where do we stand?
• Targeting the microenvironment in CLL
• What is the best time-limited therapy
• BTK inhibitors
• Small molecule resistance
• Next generation therapies
• The future: other targets
Programme
Read the final programme!

